no statement of use filed
on 09 Oct 2017
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
86028243 filed on 04th Aug 2013
Registration Number
N/A
Correspondent Address
MARILYN F. KELLY
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. The mark consists of the design of a ball and several rows of dots in a spiral formation. Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, rRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
No 86028243
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.26 -
Spirals, coils and swirls
26.17.03 -
Dotted line(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the design of a ball and several rows of dots in a spiral formation.
| Status Date | Action Taken |
|---|---|
| 10th Oct 2017 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 09th Oct 2017 | ABANDONMENT - NO USE STATEMENT FILED |
| 04th Mar 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd Mar 2017 | EXTENSION 5 GRANTED |
| 28th Feb 2017 | EXTENSION 5 FILED |
| 28th Feb 2017 | TEAS EXTENSION RECEIVED |
| 01st Sep 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 31st Aug 2016 | EXTENSION 4 GRANTED |
| 25th Aug 2016 | EXTENSION 4 FILED |
| 25th Aug 2016 | TEAS EXTENSION RECEIVED |
